| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/17/2011 | US7943636 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943617 Heterobicyclic compounds useful as kinase inhibitors |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943611 Imidazo[1,2-A]pyridin-3-yl-acetic acid hydrazides, processes, for their preparation and pharmaceutical uses thereof |
| 05/17/2011 | US7943610 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 05/17/2011 | US7943208 Materials and methods for the preparation of anisotropically-ordered solids |
| 05/17/2011 | CA2514267C Malonamide derivatives as gamma-secretase inhibitors |
| 05/17/2011 | CA2494574C 7-phenylpyrazolopyridine compounds |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/17/2011 | CA2453418C Variolin derivatives and their use as antitumor agents |
| 05/17/2011 | CA2402446C 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor activity |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/12/2011 | WO2011057148A1 Compounds and compositions as tlr-7 activity modulators |
| 05/12/2011 | WO2011057145A2 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same |
| 05/12/2011 | WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 05/12/2011 | WO2011056630A2 Small molecule inhibitors of hepatitis c virus |
| 05/12/2011 | WO2011056566A2 Compounds and methods for treatment of cancer |
| 05/12/2011 | WO2011056511A2 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase |
| 05/12/2011 | WO2011056440A1 Heterocyclic compounds as ccr1 receptor antagonists |
| 05/12/2011 | WO2011055932A2 Organic compound, organic electronic device using same, and terminal for same |
| 05/12/2011 | WO2011055911A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/12/2011 | WO2011055810A1 Dihydro pyrroloquinoline derivatives |
| 05/12/2011 | WO2011055796A1 Pyrroloquinoline quinone in free form |
| 05/12/2011 | WO2011055320A1 Imidazopyridine derivatives |
| 05/12/2011 | WO2011054885A1 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders |
| 05/12/2011 | WO2011054846A1 Imidazo [4, 5-c] quinoline derivates as bromodomain inhibitors |
| 05/12/2011 | WO2011054828A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | WO2011054433A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | WO2011027081A3 Derivatives of 5,6,7,8-tetrahydroindolizine inhibiting hsp90, compositions containing same, and use thereof |
| 05/12/2011 | WO2011005759A3 Lonidamine analogues for fertility management |
| 05/12/2011 | WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors |
| 05/12/2011 | US20110112298 Method for producing camptothecin derivatives |
| 05/12/2011 | US20110112138 Multi-cyclic cinnamide derivatives |
| 05/12/2011 | US20110112135 Imidazo [1,2-A] Pyridine Compounds |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112133 Dihydro pyrroloquinoline derivatives |
| 05/12/2011 | US20110112127 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | US20110112122 EPIMINOCYCLOALKYL[b] INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF |
| 05/12/2011 | US20110112106 Tricyclic inhibitors of 5-lipoxygenase |
| 05/12/2011 | US20110112105 Substituted heterocycle fused gamma-carbolines solid |
| 05/12/2011 | US20110112104 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | US20110112080 Oxazoline derivatives |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | US20110110927 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110890 Novel Inhibitors of Hepatitis C Virus Replication |
| 05/12/2011 | US20110110889 Raf inhibitor compounds and methods of use thereof |
| 05/12/2011 | CA2780190A1 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | CA2780111A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | CA2779951A1 Imidazopyridine derivatives |
| 05/12/2011 | CA2779935A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | CA2779539A1 Pyrroloquinoline quinone in free form |
| 05/12/2011 | CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 05/11/2011 | EP2318409A1 Method for producing 3,7-diaza-bicyclo[3.3.1]nonane compounds |
| 05/11/2011 | EP2318408A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318407A1 Pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318406A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 05/11/2011 | EP2318405A2 Paliperidone ketone |
| 05/11/2011 | EP2318404A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 05/11/2011 | EP2318389A1 Pyridazine derivatives as smo inhibitors |
| 05/11/2011 | EP2318382A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 05/11/2011 | EP2318378A2 Quinazoline derivatives |
| 05/11/2011 | EP2318367A1 Piperidine and pyrrolidine compounds |
| 05/11/2011 | EP2318363A1 Heterocyclic derivatives as iap binding compounds |
| 05/11/2011 | EP2094703B1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 05/11/2011 | EP1606254B1 2,4,6-phenyl substituted cyclic ketoenols |
| 05/11/2011 | EP1594870B1 Substituted indolepyridinium as anti-infective compounds |
| 05/11/2011 | CN102057015A Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
| 05/11/2011 | CN102056927A Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 05/11/2011 | CN102056926A Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 05/11/2011 | CN102056925A Compounds and compositions as kinase inhibitors |
| 05/11/2011 | CN102056921A Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 05/11/2011 | CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 05/11/2011 | CN102056904A Indane derivatives as AMPA receptor modulators |
| 05/11/2011 | CN102050841A 2-propionamide-1,10-phenanthroline anil coordination compound, preparation method thereof, catalyst comprising same and application thereof |
| 05/11/2011 | CN102050822A Method for extracting tabersonine from voacanga seed |
| 05/11/2011 | CN102050821A Novel imidazo(1,5-a)pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/11/2011 | CN102050776A 5-substituted methylpyrrolidine-2, 4-diketone compound and use thereof |
| 05/11/2011 | CN101619064B Synthesis and process method for novel polynitrogen heterocycle pharmaceutical intermediates |
| 05/11/2011 | CN101346377B Aryl-isoxazol-4-yl-imidazoy1, 5-A pyridine derivatives |
| 05/11/2011 | CN101250188B Technique for preparing willow leaf tabersonine |
| 05/11/2011 | CN101190914B 16-site substituted double functional group huperzine B derivative, preparation method and use thereof |
| 05/11/2011 | CN101065379B Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 05/11/2011 | CN101052640B Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors |
| 05/11/2011 | CN101027302B Pyrrolo-pyridine kinase modulators |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939666 Enzyme inhibitors |
| 05/10/2011 | US7939657 N-substituted benzene sulfonamides |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939538 Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 05/10/2011 | US7939526 Sulfone substituted imidazo ring ethers |
| 05/10/2011 | CA2473572C Quinazoline compounds |
| 05/10/2011 | CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/05/2011 | WO2011053977A1 Compounds and methods for inhibiting serotonin synthesis |
| 05/05/2011 | WO2011053476A1 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition |
| 05/05/2011 | WO2011052721A1 Organic semiconductor material, organic semiconductor thin film, and organic thin film transistor |